{
    "clinical_study": {
        "@rank": "114125", 
        "arm_group": [
            {
                "arm_group_label": "AMBU Aura-I/aScope 2", 
                "arm_group_type": "Experimental", 
                "description": "First, the AMBU Aura-I LMA will be inserted. Then, then patient will be intubated with assistance of the AMBU aScope 2 disposable fiberoptic system."
            }, 
            {
                "arm_group_label": "LMA Fastrach", 
                "arm_group_type": "Experimental", 
                "description": "The LMA Fastrach Single Use Laryngeal Mask Airway (The Laryngeal Mask Airway Company, California) will be placed, followed by blind intubation using the LMA Fastrach EndoTracheal Tube."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to compare the Ambu\u00ae Aura-I  to the Intubating Laryngeal Mask\n      Airway (LMA) regarding time to intubate, ease of insertion, sealing properties, optical view\n      upon fiberoptic examination regarding the Ambu Aura-I, ease and success rate of intubation,\n      airway morbidity, and patient comfort in patients undergoing general anesthesia for elective\n      surgery."
        }, 
        "brief_title": "AMBU AScope2 Fiberoptic Intubation Versus Fastrach Intubating LMA", 
        "completion_date": {
            "#text": "November 2012", 
            "@type": "Anticipated"
        }, 
        "condition": "Laryngeal Mask Airways as a Conduit for Intubation", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Adult surgical Candidates Aged 18-80 years\n\n          -  ASA I-III\n\n          -  Mallampati Score of I or II\n\n          -  BMI \u2264 35 kg/m2\n\n          -  Presenting for elective surgery\n\n          -  Require General Endotracheal Anesthesia.\n\n        Exclusion Criteria:\n\n          -  Previously known difficult airway,\n\n          -  Emergency status\n\n          -  Require prone positioning\n\n          -  Interincisor distance < 2.5cm\n\n          -  Thyromental distance < 5cm\n\n          -  Clinically suspected difficult airway\n\n          -  Contraindications to LMA Insertion, such as Reflux disease\n\n          -  Patients who do not require endotracheal intubation\n\n          -  Indications for Rapid Sequence Induction (RSI)"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "66", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 30, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01656967", 
            "org_study_id": "HSC-MS-10-0604"
        }, 
        "intervention": [
            {
                "arm_group_label": "AMBU Aura-I/aScope 2", 
                "intervention_name": "AMBU Aura-I LMA and aScope 2 Disposable Fiberoptic Camera", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "LMA Fastrach", 
                "intervention_name": "LMA Fastrach Single Use", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Laryngeal Mask Airway", 
            "LMA", 
            "Intubation", 
            "AMBU", 
            "AScope", 
            "Aura-I", 
            "Fastrach", 
            "Fiberoptic", 
            "Disposable Fiberoptic", 
            "Blind Intubation", 
            "Fiberoptic Intubation"
        ], 
        "lastchanged_date": "August 2, 2012", 
        "location": {
            "facility": {
                "address": {
                    "city": "Houston", 
                    "country": "United States", 
                    "state": "Texas", 
                    "zip": "77030"
                }, 
                "name": "Memorial Hermann Hospital - Texas Medical Center"
            }, 
            "investigator": [
                {
                    "last_name": "Carin A Hagberg, MD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Carlos Artime, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Katherine Normand, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Lara Ferrario, MD", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Flexible Optical Intubation Via the AMBU Aura-I Versus Blind Intubation Via the Fastrach Single Use Intubating LMA - A Prospective Randomized Clinical Trial", 
        "other_outcome": {
            "description": "Following LMA Insertion, the LMA cuff pressure will be calibrated using a manometer until it is 60-70 cm H2O. Leak pressure will then be assessed.", 
            "measure": "LMA Cuff Sealing Properties", 
            "safety_issue": "No", 
            "time_frame": "Following LMA Insertion (Approximately 3-5 minutes)"
        }, 
        "overall_contact": {
            "email": "Carin.A.Hagberg@uth.tmc.edu", 
            "last_name": "Carin A Hagberg, MD", 
            "phone": "(713) 500-6200"
        }, 
        "overall_contact_backup": {
            "email": "Alfonso.V.Altamirano@uth.tmc.edu", 
            "last_name": "Alfonso V Altamirano, MD", 
            "phone": "(713) 500-6304"
        }, 
        "overall_official": {
            "affiliation": "The University of Texas Medical School at Houston", 
            "last_name": "Carin A Hagberg, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "November 2012", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Total Intubation Time includes time for LMA insertion and Tube Insertion.", 
            "measure": "Total Intubation Time", 
            "safety_issue": "No", 
            "time_frame": "The Duration of Intubation. Calculated by addition of LMA insertion time and ETT insertion time (Approximately 40 - 250 seconds)"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01656967"
        }, 
        "responsible_party": {
            "investigator_affiliation": "The University of Texas Health Science Center, Houston", 
            "investigator_full_name": "Carin A. Hagberg", 
            "investigator_title": "Professor and Chair, Department of Anesthesiology", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Time required to insert LMA. The AMBU Aura-I LMA will be used in Group 1, whereas the Fastrach Single Use Intubating LMA will be used for Group 2 patients. Time will be recorded from when the LMA is at the patient's lips to when a CO2 trace is recorded.", 
                "measure": "Time for LMA Insertion", 
                "safety_issue": "No", 
                "time_frame": "LMA Insertion from the time the LMA cuff is placed at the patient's lips until the a CO2 tracing is observed (Approximately 20-100 seconds)"
            }, 
            {
                "description": "After the LMA is inserted, time for intubation will be recorded. The AScope 2 disposable fiberoptic camera will be used to assist with intubation for Group 1 patients. Group 2 patients will be intubated using the LMA-Fastrach EndoTracheal Tube.", 
                "measure": "Intubation Time", 
                "safety_issue": "No", 
                "time_frame": "Duration of Tube Insertion, From the time the Tube is at the patient's lips until a CO2 tracing is recorded (Approximately 40-250 seconds)"
            }, 
            {
                "description": "Number of attempts required for successful intubation will be recorded.", 
                "measure": "Intubation Success Rate", 
                "safety_issue": "No", 
                "time_frame": "Duration of Intubation (Approximately 3 minutes)"
            }, 
            {
                "description": "Subjective Difficulty of intubation will be recorded by the intubationist on a 5 point scale: 1- Very Easy 2- Easy 3- Slight Resistance 4- Difficult 5- Not Possible. Separate scores will be recorded for LMA Insertion, Tube Insertion, and aScope Insertion (Group 1 patients).", 
                "measure": "Subjective Ease of Intubation", 
                "safety_issue": "No", 
                "time_frame": "Duration of Intubation (Approximately 3 minutes)"
            }, 
            {
                "description": "The patient will be assessed for Post-Operative Hoarseness, Sore Mouth, Sore Neck, Sore Jaw, Dysphonia, Dysphagia and Altered Tongue Sensation on entrance to Post-Anesthesia Care United (PACU) and on exit from PACU.", 
                "measure": "Post-Operative Discomfort", 
                "safety_issue": "No", 
                "time_frame": "Duration of stay in Post-Anesthesia Care Unit (Approximately 1-2 hours)"
            }
        ], 
        "source": "The University of Texas Health Science Center, Houston", 
        "sponsors": {
            "collaborator": {
                "agency": "AMBU A/S (Ballerup, Denmark)", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "The University of Texas Health Science Center, Houston", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2010", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label", 
        "study_type": "Interventional", 
        "verification_date": "July 2012"
    }
}